The Claim
Oral glutamine supplementation at 30 g/day during radiochemotherapy for advanced esophageal cancer is associated with reduced gut barrier permeability, as measured by lower urinary excretion of phenolsulfonphthalein, compared to no supplementation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with advanced esophageal cancer undergoing radiochemotherapy, taking 30 grams of glutamine daily by mouth is associated with lower levels of phenolsulfonphthalein in urine, indicating reduced gut barrier permeability compared to not taking glutamine.
See the scientific wording
Oral glutamine supplementation at 30 g/day during radiochemotherapy for advanced esophageal cancer is associated with reduced gut barrier permeability, as measured by lower urinary excretion of phenolsulfonphthalein, compared to no supplementation.
Glutamine from supplements is absorbed and used by gut lining cells as fuel to stay healthy and repair themselves. It also helps make a molecule that neutralizes damage from cancer treatment. This keeps the tight seals between gut cells intact, so harmful substances cannot leak into the bloodstream and appear in urine.
What the research says
1 studyTaking 30 grams of glutamine daily during cancer treatment helped keep the gut lining intact, so fewer harmful substances leaked into the urine — meaning the gut stayed healthier than in patients who didn’t take glutamine.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.